Phenotypic Screening in <i>C. elegans</i> as a Tool for the Discovery of New Geroprotective Drugs
Population aging is one of the largest challenges of the 21st century. As more people live to advanced ages, the prevalence of age-related diseases and disabilities will increase placing an ever larger burden on our healthcare system. A potential solution to this conundrum is to develop treatments t...
Main Authors: | Sven Bulterijs, Bart P. Braeckman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/8/164 |
Similar Items
-
Geroprotective properties of neuroprotective and neurotrophic peptides
by: O. A. Gromova, et al.
Published: (2020-02-01) -
Cell and small animal models for phenotypic drug discovery
by: Szabo M, et al.
Published: (2017-06-01) -
Fragment-based screening: A new paradigm for ligand and target discovery
by: Sinéad Knight, et al.
Published: (2022-01-01) -
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
by: José T. Moreira-Filho, et al.
Published: (2021-05-01) -
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
by: Balachandra Bandodkar, et al.
Published: (2020-08-01)